N-acetylcysteine+nimesulide: An association strategy aiming to prevent nimesulide-induced hepatotoxicity
DOI:
https://doi.org/10.12957/bjhbs.2020.59709Keywords:
Nimesulide, N-acetylcysteine, Safety, Hepatotoxicity, Anti-inflammatory.Abstract
Introduction: Nimesulide is a potent anti-inflammatory
with rapid and long-lasting effects, but also with a high risk
of hepatotoxicity. Objective: This work aimed to prevent
nimesulide-induced hepatotoxicity through the association
of nimesulide with a hepatoprotective agent. Materials and
Methods: First, we tested three hepatoprotective agents:
N-acetylcysteine, L-carnitine, and Gingko biloba extract in
an in vitro hepatic cell model. Both N-acetylcysteine and G.
biloba showed promisor results. We selected N-acetylcysteine
to continue the studies in an animal model. In vivo study was
performed using male Wistar rats divided in 4 groups: control,
nimesulide (100mg/kg/day), nimesulide (100mg/kg/day) +
N-acetylcysteine (100mg/kg/day) and N-acetylcysteine alone
(100mg/kg/day). Treatments were given by gavage, daily, for
15 days. Results: Animals receiving nimesulide alone showed
lower body weight gain compared to control. Body weight
gain in the nimesulide + N-acetylcysteine group was higher
than nimesulide alone, evidencing lower toxicity. However,
the body weight gain of the nimesulide + N-acetylcysteine
group was still lower than the control animals. Animals treated
with nimesulide alone presented an increased relative mass of
heart, liver, and spleen and significant hepatic damage seen in
microscopy when compared to other groups. N-acetylcysteine
co-administered with nimesulide prevented the increased
heart mass, but the same was not true with liver and spleen.
Conclusions: This work evidence partial protection elicited
by the association of N-acetylcysteine and nimesulide against
nimesulide-induced hepatotoxicity.
References
Risser A, Donovan D, Heintzman J, et al. NSAID prescribing
precautions. Am Fam Physician. 2009;80(12):1371–8.
Sousa JM de, Neto MF de A, et al. Ação Anti-inflamatória da
Nimesulida e seu grau de Hepatotoxidade. Revista Científica do
ITPAC. 2016 Feb;
Bianchi M, Ferrario P, Balzarini P, et al. Plasma and synovial
fluid concentrations of nimesulide and its main metabolite after
a single or repeated oral administration in patients with knee
osteoarthritis. J Int Med Res. 2006;34(4):348–54.
Silva NA da, Marczyk LRS. Eficácia e tolerabilidade da nimesulida
versus celecoxib na osteoartrite. Acta Ortopédica Bras.
;9(1):42–54.
Adams RJ, Appleton SL, Gill TK, et al. Cause for concern in
the use of non-steroidal anti-inflammatory medications in the
community -A population-based study. BMC Family Practice.
;12(1):70.
Arrais PSD, Fernandes MEP, Pizzol T da SD, et al. Prevalence
of self-medication in Brazil and associated factors. Revista de
Saude Publica. 2016;50(supl 2):1–11.
Bessone F. Non-steroidal anti-inflammatory drugs: What
is the actual risk of liver damage? World J Gastroenterol.
;16(45):5651–61.
Licata A, Calvaruso V, Cappello M, et al. Clinical course and
outcomes of drug-induced liver injury : Nimesulide as the first
implicated medication. 2010;42:143–8.
OPAS. Hepatotoxicidad grave asociada con el uso de nimesulida.
Bol Inf la Red Centros Inf Medicam Lat y el Caribe, Organ
Pan-Americana da Saúde. 2017;(5):1–12.
Navarro VJ, Senior JR. Drug-related hepatotoxicity. N Engl J
Med. 2006;354(7):731–9.
Edited by Rainsford KD. Nimesulide - Actions and Uses.
Birkhäuser Verlag, P.O. Box 133, CH-4010 Basel, Switzerland;
1–445 p.
Benlamkaddem S, Iken I, Houari N, et al. Paracetamol self-poisoning:
When oral N-acetylcysteine saves life? A case report.
Pan Afr Med J. 2018;29:1–5.
Yesil Y, Ozdemir AA. Evaluation of the children with acute
acetaminophen overdose and intravenous N-acetylcysteine
treatment. 2018;34(3):590–4.
Heil J, Schultze D, Schemmer P, et al. N-acetylcysteine protects
hepatocytes from hypoxia-related cell injury. Clin Exp Hepatol.
;4(4):260–6.
Masi F, Leggio B, Nanni G, et al. Effects of long-term
acetyl-L-carnitine administration in rats—II: Protection against
the disrupting effect of stress on the acquisition of appetitive
behavior. Neuropsychopharmacology. 2003;28(4):683–93.
Rebouche CJ. Kinetics, pharmacokinetics, and regulation of
L-carnitine and acetyl-L-carnitine metabolism. Ann N Y Acad
Sci. 2004;1033:30–41.
Diamond BJ, Bailey MR. Ginkgo biloba. Indications, Mechanisms,
and Safety. Psychiatr Clin North Am. 2013;36(1):73–83.
Waidyanatha S, Mutlu E, Gibbs S, et al. Systemic exposure
to Ginkgo biloba extract in male F344/NCrl rats: Relevance to
humans. Food Chem Toxicol. 2019;131:110586.
Rossato LG, Costa VM, Vilas-Boas V, et al. Therapeutic concentrations
of mitoxantrone elicit energetic imbalance in H9c2
cells as an earlier event. Cardiovasc Toxicol. 2013;13(4):413–
Arbo MD, Silva R, Barbosa DJ, et al. Piperazine designer drugs
induce toxicity in cardiomyoblast h9c2 cells through mitochondrial
impairment. Toxicol Lett. 2014;229(1):178–89.
Patel PB, Patel TK, Patni S, et al. Hepatotoxicity Studies of
Nimesulide in Litters of Rat. 364001.
Calegari EM, Endres HC, Dallegrave E, et al. Silymarin elicits
partial protection against methotrexate-induced hepatotoxicity in
wistar rats. Int J Pharm Pharm Sci. 2015;7(9):462–5.
Bradford MM. A Rapid and Sensitive Method for the Quantitation
of Microgram Quantities of Protein Utilizing the Principle of
Protein-Dye Binding. 1976;254:481.
Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in
animal tissues by thiobarbituric acid reaction. Anal Biochem.
;95(2):351–8.
Elmann GL. Tissue sulfhydryl groups. Arch Biochem Biophys
;82:70-7.
Raza M, Ahmad M, Gado A. A comparison of hepatoprotective
activities of aminoguanidine and N -acetylcysteine in rat against
the toxic damage induced by azathioprine. 2003;134:451–6.
Prescott LF, Illingworth RN, Adam RD. Intravenous N-acetylcysteine
: the treatment of choice for paracetamol poisoning.
;(November):1097–100.
Mumtaz K, Azam Z, Hamid S, et al. Role of N-acetylcysteine
in adults with non-acetaminophen-induced acute liver failure in
a center without the facility of liver transplantation. Hepatology
International. 2009;3(4):563–70.
Al C, Gluud C, Brok J, et al. Interventions for paracetamol (
acetaminophen ) overdose ( Review ) Summary of Findings
for the main Comparison. Cochrane Database Syst Rev.
;(2):1–90.
Athuraliya TNC, Jones AL. Prolonged N-acetylcysteine therapy
in late acetaminophen poisoning associated with acute liver failure
– a need to be more cautious? Crit Care. 2009;13(3):144.
Whillier S, Raftos JE, Chapman B, et al. Role of N-acetylcysteine
and cystine in glutathione synthesis in human erythrocytes.
;0002.
Traversa G. Cohort study of hepatotoxicity associated with nimesulide
and other non-steroidal anti-inflammatory drugs. BMJ.
;327(7405):18–22.
Liu H, Lee SS. Cirrhotic cardiomyopathy. Cirrhosis A Pract Guid
to Manag. 2015;56(7):225–35.
Tao Y, Wang M, Chen E, et al. Liver Regeneration: Analysis of
the Main Relevant Signaling Molecules. Mediators Inflamm.
;2017:4256352. doi: 10.1155/2017/4256352.
Tolu P, Masi F, Leggio B, et al. Effects of long-term acetyl-L-carnitine
administration in rats: I. Increased dopamine output in
mesocorticolimbic areas and protection toward acute stress
exposure. Neuropsychopharmacology. 2002;27(3):410–20.
Hoang BX, Graeme Shaw D, Pham P, et al. Restoration of cellular
energetic balance with l-carnitine in the neuro-bioenergetic
approach for cancer prevention and treatment. Med Hypotheses.
;69(2):262–72.
Bovell DL, Clunes MT, Elder HY, et al. L-carnitine prevents
increase in diastolic [Ca2+] induced by doxorubicin in cardiac
cells. 2000;45–8.
Downloads
Published
How to Cite
Issue
Section
License
After the final approval, authors must send the copyright transfer agreement signed by the first author representing each additional author. In this agreement must be stated any conflicts of interest.
Brazilian Journal of Health and Biomedical Sciences de http://bjhbs.hupe.uerj.br/ is licensed under a License Creative Commons - Attribution-NonCommercial 4.0 International. 
